88 related articles for article (PubMed ID: 8121719)
1. [Toxic effect of two antitumoral agents derived from platinum, the cisplatin and the oxaliplatin on primary cultures of proximal tubular cells of the kidney in rabbits].
Legallicier B; Leclere C; Monteil C; Morin JP; Fillastre JP
Pathol Biol (Paris); 1993 Nov; 41(9):873-80. PubMed ID: 8121719
[TBL] [Abstract][Full Text] [Related]
2. The cellular toxicity of two antitumoural agents derived from platinum, cisplatinum versus oxaliplatinum, on cultures of tubular proximal cells.
Legallicier B; Leclere C; Monteil C; Elkaz V; Morin JP; Fillastre JP
Drugs Exp Clin Res; 1996; 22(2):41-50. PubMed ID: 8879978
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
4. Platinum complex-induced dysfunction of cultured renal proximal tubule cells. A comparative study of carboplatin and transplatin with cisplatin.
Courjault F; Leroy D; Coquery L; Toutain H
Arch Toxicol; 1993; 67(5):338-46. PubMed ID: 8396390
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin nephrotoxicity and platinum-metallothioneins: uptake and toxicity in proximal tubular cells from rat kidney.
Boogaard PJ; Mulder GJ; Nagelkerke JF
Contrib Nephrol; 1990; 83():208-12. PubMed ID: 2100713
[No Abstract] [Full Text] [Related]
6. Cilastatin attenuates cisplatin-induced proximal tubular cell damage.
Camano S; Lazaro A; Moreno-Gordaliza E; Torres AM; de Lucas C; Humanes B; Lazaro JA; Milagros Gomez-Gomez M; Bosca L; Tejedor A
J Pharmacol Exp Ther; 2010 Aug; 334(2):419-29. PubMed ID: 20435919
[TBL] [Abstract][Full Text] [Related]
7. Platinum-induced kidney damage: Unraveling the DNA damage response (DDR) of renal tubular epithelial and glomerular endothelial cells following platinum injury.
Krüger K; Thomale J; Stojanović N; Osmak M; Henninger C; Bormann S; Fritz G
Biochim Biophys Acta; 2015 Mar; 1853(3):685-98. PubMed ID: 25565603
[TBL] [Abstract][Full Text] [Related]
8. Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines.
Virag P; Perde-Schrepler M; Fischer-Fodor E; Tatomir C; Dorneanu SA; Cernea VI; Irimie A
Anticancer Drugs; 2012 Nov; 23(10):1032-8. PubMed ID: 22614106
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.
Haschke M; Vitins T; Lüde S; Todesco L; Novakova K; Herrmann R; Krähenbühl S
Nephrol Dial Transplant; 2010 Feb; 25(2):426-33. PubMed ID: 19736245
[TBL] [Abstract][Full Text] [Related]
10. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
Kim WK; Kwon YE
Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
[TBL] [Abstract][Full Text] [Related]
11. Organic cation transporters are determinants of oxaliplatin cytotoxicity.
Zhang S; Lovejoy KS; Shima JE; Lagpacan LL; Shu Y; Lapuk A; Chen Y; Komori T; Gray JW; Chen X; Lippard SJ; Giacomini KM
Cancer Res; 2006 Sep; 66(17):8847-57. PubMed ID: 16951202
[TBL] [Abstract][Full Text] [Related]
12. The immediate early genes, c-fos, c-jun and AP-1, are early markers of platinum analogue toxicity in human proximal tubular cell primary cultures.
Wainford RD; Weaver RJ; Hawksworth GM
Toxicol In Vitro; 2009 Aug; 23(5):780-8. PubMed ID: 19383537
[TBL] [Abstract][Full Text] [Related]
13. Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption.
Kim YK; Byun HS; Kim YH; Woo JS; Lee SH
Toxicol Appl Pharmacol; 1995 Jan; 130(1):19-26. PubMed ID: 7839366
[TBL] [Abstract][Full Text] [Related]
14. Involvement of macromolecule synthesis, endonuclease activation and c-fos expression in cisplatin-induced apoptosis of mouse proximal tubule cells.
Takeda M; Kobayashi M; Shirato I; Endou H
Toxicol Lett; 1998 Jan; 94(2):83-92. PubMed ID: 9574805
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin nephrotoxicity and protection by silibinin.
Gaedeke J; Fels LM; Bokemeyer C; Mengs U; Stolte H; Lentzen H
Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin and oxaliplatin inhibit gap junctional communication by direct action and by reduction of connexin expression, thereby counteracting cytotoxic efficacy.
Wang Q; You T; Yuan D; Han X; Hong X; He B; Wang L; Tong X; Tao L; Harris AL
J Pharmacol Exp Ther; 2010 Jun; 333(3):903-11. PubMed ID: 20215407
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity.
Pourahmad J; Hosseini MJ; Eskandari MR; Shekarabi SM; Daraei B
Xenobiotica; 2010 Nov; 40(11):763-71. PubMed ID: 20809784
[TBL] [Abstract][Full Text] [Related]
18. Panax notoginseng saponins attenuated cisplatin-induced nephrotoxicity.
Liu SJ; Zhou SW
Acta Pharmacol Sin; 2000 Mar; 21(3):257-60. PubMed ID: 11324427
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cytotoxicities of platinum compounds.
Goodisman J; Hagrman D; Tacka KA; Souid AK
Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate reduces cisplatin-induced apoptosis of renal proximal tubular cells via inhibition of JNK and p38 pathways.
Thongnuanjan P; Soodvilai S; Chatsudthipong V; Soodvilai S
J Toxicol Sci; 2016; 41(3):339-49. PubMed ID: 27193727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
